Intuitive Surgical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Intuitive Surgical, Inc. (ISRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $640.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-03
- Intuitive Surgical, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $640.00M, a 18.88% decline from fiscal 2024.
- Intuitive Surgical, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $789.00M, a 65.76% increase from fiscal 2023.
- Intuitive Surgical, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $476.00M, a 51.11% increase from fiscal 2022.
- Intuitive Surgical, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $315.00M, a 48.61% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $640.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $789.00M 10-K · filed 2026-02-03 | |
| 2023-12-31 | $476.00M 10-K · filed 2026-02-03 | |
| 2022-12-31 | $315.00M 10-K · filed 2025-01-31 | |
| 2021-12-31 | $613.00M 10-K · filed 2024-01-31 | |
| 2020-12-31 | $598.00M 10-K · filed 2023-02-10 | |
| 2019-12-31 | $512.00M 10-K · filed 2022-02-03 | |
| 2018-12-31 | $527.00M 10-K · filed 2021-02-10 | $526.60M 10-K · filed 2019-02-04 |
| 2017-12-31 | $379.90M 10-K · filed 2020-02-07 | |
| 2016-12-31 | $273.30M 10-K · filed 2019-02-04 | |
| 2015-12-31 | $196.50M 10-K · filed 2018-02-02 | |
| 2014-12-31 | $146.20M 10-K · filed 2017-02-06 | |
| 2013-12-31 | $130.20M 10-K · filed 2016-02-02 | |
| 2012-12-31 | $375.70M 10-K · filed 2015-02-06 | |
| 2011-12-31 | $262.80M 10-K · filed 2014-02-03 | |
| 2010-12-31 | $192.90M 10-K · filed 2013-02-04 | |
| 2009-12-31 | $94.90M 10-K · filed 2012-02-06 | |
| 2008-12-31 | $140.90M 10-K · filed 2011-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |